Stoke Therapeutics

$1.4M revenue • 8 employees • United States

Last Updated May 8, 2025

Company Overview

Company Name

Stoke Therapeutics

Address

United States

Approx. Annual Revenue

$1.4M

Employees

8

Established

2016

About Stoke Therapeutics

Stoke Therapeutics is a biopharmaceutical company based in the United States that is focused on developing RNA-based therapies to address genetic diseases. The company's proprietary TANGO platform aims to restore missing proteins by increasing protein output from healthy genes, compensating for non-functioning gene copies.

More Companies in New York

Browse all companies in New York →

Frequently Asked Questions about Stoke Therapeutics

Categories

Social Profiles

Key Decision Makers

Isabel Aznarez Co-Founder
LinkedIn
Stephanie Patriarca Senior Clinical DMPK Study Manager
LinkedIn
Amber Rawat Sr. Clinical Trial Manager
LinkedIn